The effect of a polyurethane-based reverse thermal gel on bone marrow stromal cell transplant survival and spinal cord repair

Biomaterials

Volumn 35, Issue 6, 2014, Pages 1924-1931

  Ritfeld, Gaby J ^a,f   Rauck, Britta M ^b,d   Novosat, Tabitha L ^a   Park, Daewon ^a,e   Patel, Pavan ^a   Roos, Raymund A C ^f   Wang, Yadong ^b,c,d   Oudega, Martin ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e The University of Colorado Denver   (United States)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antioxidant; Cell therapy; ESHU; Neuroprotection; Repair; Spinal cord injury

Indexed keywords

ANTIOXIDANTS; CELL DEATH; POLYETHYLENE GLYCOLS; POLYURETHANES; REPAIR; TISSUE; TISSUE REGENERATION;

BONE MARROW STROMAL CELLS; CELL THERAPY; DNA OXIDATION; ESHU; NERVOUS TISSUES; NEUROPROTECTION; SPINAL CORD INJURIES (SCI); SPINAL CORDS;

BONE;

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; CASPASE 3; DNA; HYDROGEN PEROXIDE; POLY(ETHYLENE GLYCOL) POLY(SERINOL HEXAMETHYLENE URETHANE; POLYURETHAN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL THERAPY; CELL TRANSPLANTATION; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FUNCTIONAL ASSESSMENT; GEL; GRAFT SURVIVAL; HINDLIMB; MOTOR PERFORMANCE; NERVOUS TISSUE; NEUROPROTECTION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SPINAL CORD CONTUSION; SPINAL CORD INJURY; SPINAL CORD REGENERATION; STROMA CELL; TEMPERATURE; TREATMENT OUTCOME;

RATTUS;

ANTIOXIDANT; CELL THERAPY; ESHU; NEUROPROTECTION; REPAIR; SPINAL CORD INJURY;

ANIMALS; ANTIOXIDANTS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; FEMALE; GELS; IMMUNOHISTOCHEMISTRY; POLYURETHANES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; SPINAL CORD REGENERATION; STROMAL CELLS;

EID: 84890151166     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.062     Document Type: Article

References (54)

1. Okano H., Nakamura M., Yoshida K., Okada Y., Tsuji O., Nori S., et al. Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 2013, 112(3):523-533.
2. Ruff C.A., Fehlings M.G. Neural stem cells in regenerative medicine: bridging the gap. Panminerva Med 2010, 52(2):125-147.
3. Forraz N., Wright K., Jurga M., McGuckin C. Experimental therapies for repair of the central nervous system: stem cells and tissue engineering. JTissue Eng Regen Med 2013, 7(7):523-536.
4. Hofstetter C.P., Schwarz E.J., Hess D., Widenfalk J., El Manira A., Prockop D.J., et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002, 99(4):2199-2204.
5. Himes B.T., Neuhuber B., Coleman C., Kushner R., Swanger S.A., Kopen G.C., et al. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair 2006, 20(2):278-296.
6. Mahmood A., Lu D., Wang L., Chopp M.J. Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. Neurotrauma 2002, 19(12):1609-1617.
7. Ritfeld G.J., Nandoe Tewarie R.D., Vajn K., Rahiem S.T., Hurtado A., Roos R.A.C., et al. Bone marrow stromal cell-mediated tissue sparing enhances functional repairafter spinal cord contusion in adult rats. Cell Transplant 2012, 21(7):1561-1575.
8. Tschöpe C., Miteva K., Schultheiss H.P., Linthout S.V. Mesenchymal stromal cells: a promising cell source for the treatment of inflammatory cardiomyopathy. Curr Pharm Des 2011, 17(30):3295-3307.
9. Ichim T.E., Alexandrescu D.T., Solano F., Lara F., Campion Rde N., Paris E., et al. Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol 2010, 260(2):75-82.
10. Zou J.P., Huang S., Peng Y., Liu H.W., Cheng B., Fu X.B., et al. Mesenchymal stem cells/multipotent mesenchymal stromal cells (MSCs): potential role in healing cutaneous chronic wounds. Int J Low Extrem Wounds 2012, 11(4):244-253.
11. Bernardo M.E., Pagliara D., Locatelli F. Mesenchymal stromal cell therapy: a revolution in regenerative medicine?. Bone Marrow Transplant 2012, 47(2):164-171.
12. Mahmood A., Lu D., Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. JNeurotrauma 2004, 21:33-39.
13. Al Caplan Why are MSCs therapeutic? New data: new insight. JPathol 2009, 217(2):318-324.
14. Hawryluk G.W., Mothe A., Wang J., Wang S., Tator C., Fehlings M.G. An invivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev 2012, 21(12):2222-2228.
15. Nandoe Tewarie R.D., Hurtado A., Ritfeld G.J., Rahiem S.T., Wendell D.F., Barroso M.M., et al. Bone marrow stromal cells elicit tissue sparing after acute but not delayed transplantation into the contused adult rat thoracic spinal cord. JNeurotrauma 2009, 26(12):2313-2322.
16. Ritfeld G.J., Nandoe Tewarie R.D., Rahiem S.T., Hurtado A., Roos R.A., Grotenhuis A., et al. Reducing macrophages to improve bone marrow stromal cell survival in the contused spinal cord. Neuroreport 2010, 21(3):221-226.
17. Swanger S.A., Neuhuber B., Himes B.T., Bakshi A., Fischer I. Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord. Cell Transplant 2005, 14(10):775-786.
18. Parr A.M., Kulbatski I., Wang X.H., Keating A., Tator C.H. Fate of transplanted adult neural stem/progenitor cells and bone marrow-derived mesenchymal stromal cells in the injured adult rat spinal cord and impact on functional recovery. Surg Neurol 2008, 70(6):600-607.
19. Kigerl K.A., Ankeny D.P., Garg S.K., Wei P., Guan Z., Lai W., et al. System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity invivo. Exp Neurol 2012, 233(1):333-341.
20. Facchinetti F., Dawson V.L., Dawson T.M. Free radicals as mediators of neuronal injury. Cell Mol Neurobiol 1998, 18(6):667-682.
21. Kong Q., Lin C.L. Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell Mol Life Sci 2010, 67(11):1817-1829.
22. Hamann K., Durkes A., Ouyang H., Uchida K., Pond A., Shi R. Critical role of acrolein in secondary injury following exvivo spinal cord trauma. JNeurochem 2008, 107(3):712-721.
23. 2-induced cytotoxicity and increases transplanted Schwann cell survival in a cervical hemicontusion spinal cord injury model. JNeurochem 2010, 115(4):864-872.
24. Syntichaki P., Tavernarakis N. The biochemistry of neuronal necrosis: rogue biology?. Nat Rev Neurosci 2003, 4:672-684.
25. Park D., Wu W., Wang Y. Afunctionalizable reverse thermal gel based on a polyurethane/PEG block copolymer. Biomaterials 2011, 32(3):777-786.
26. Park D., Shah V., Rauck B.M., Friberg T.R., Wang Y. An anti-angiogenic reverse thermal gel as a drug-delivery system for age-related wet macular degeneration. Macromol Biosci 2013, 13(4):464-469.
27. Friberg T.R., Park D., Shah V., Rauck B., Medina C., Wang Y. Biodegradable and injectable in situ gelling solution controls the release of bevacizumab (avastin) invivo. ARVO annual meeting 2012.
28. Christenson E.M., Anderson J.M., Hiltner A. Oxidative mechanisms of poly(carbonate urethane) and poly(ether urethane) biodegradation: invivo and invitro correlations. JBiomed Mater Res A 2004, 70(2):245-255.
29. McBane J.E., Santerre J.P., Labow R.S. The interaction between hydrolytic and oxidative pathways in macrophage-mediated polyurethane degradation. JBiomed Mater Res A 2007, 82(4):984-994.
30. Oudega M. Schwann cell and olfactory ensheathing cell implantation for repair of the contused spinal cord. Acta Physiol (Oxf) 2007, 189(2):181-189.
31. Azizi S.A., Stokes D., Augelli B.J., DiGirolamo C., Prockop D.J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - similarities to astrocyte grafts. Proc Natl Acad Sci U S A 1998, 95(7):3908-3913.
32. Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. JCell Physiol 1999, 181(1):67-73.
33. Seshi B., Kumar S., Sellers D. Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages. Blood Cells Mol Dis 2000, 26(3):234-246.
34. Kakulas B.A. Areview of the neuropathology of human spinal cord injury with emphasis on special features. JSpinal Cord Med 1999, 22(2):119-124.
35. Bunge R., Bunge R.P., Puckett W.R., Becerra J.L., Marcillo A., Quencer R.M. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 1993, 59:75-89.
36. Scheff S.W., Rabchevsky A.G., Fugaccia I., Main J.A. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. JNeurotrauma 2003, 20:179-193.
37. Basso D.M., Beattie M.S., Bresnahan J.C. Asensitive and reliable locomotor rating scale for open field testing in rats. JNeurotrauma 1995, 12:1-21.
38. Basso D.M., Beattie M.S., Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996, 139:244-256.
39. Lankhorst A.J., Verzijl M.R., Hamers F.P.T. Experimental spinal cord contusion injury: comparison of different outcome parameters. Neurosci Res Commun 1999, 24:135-148.
40. Joosten E.A., Veldhuis W.B., Hamers F.P.T. Collagen containing neonatal astrocytes stimulates regrowth of injured fibers and promotes modest locomotor recovery after spinal cord injury. JNeurosci Res 2004, 77(1):127-142.
41. Bolton D.A., Tse A.D., Ballermann M., Misiaszek J.E., Fouad K. Task specific adaptations in rat locomotion: runway versus horizontal ladder. Behav Brain Res 2006, 168(2):272-279.
42. Kunkel-Bagden E., Dai H.N., Bregman B.S. Recovery of function after spinal cord hemisection in newborn and adult rats: differential effects on reflex and locomotor function. Exp Neurol 1992, 116:40-51.
43. Boyce R.W., Dorph-Petersen K.A., Lyck L., Gundersen H.J. Design-based stereology: introduction to basic concepts and practical approaches for estimation of cell number. Toxicol Pathol 2010, 38(7):1011-1025.
44. Brodbeck W.G., Nakayama Y., Matsuda T., Colton E., Ziats N.P., Anderson J.M. Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression invitro. Cytokine 2002, 18(6):311-319.
45. Moon Y.J., Lee J.Y., Oh M.S., Pak Y.K., Park K.S., Oh T.H., et al. Inhibition of inflammation and oxidative stress by Angelica dahuricae radix extract decreases apoptotic cell death and improves functional recovery after spinal cord injury. JNeurosci Res 2012, 90(1):243-256.
46. Wu L., Shan Y., Liu D. Stability, disposition, and penetration of catalytic antioxidants Mn-porphyrin and Mn-salen and of methylprednisolone in spinal cord injury. Cent Nerv Syst Agents Med Chem 2012, 12(2):122-130.
47. Hill C.E., Hurtado A., Blits B., Bahr B.A., Wood P.M., Bartlett Bunge M., et al. Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord. Eur J Neurosci 2007, 26(6):1433-1445.
48. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110(10):3499-3506.
49. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99(10):3838-3843.
50. Kawabori M., Kuroda S., Ito M., Shichinohe H., Houkin K., Kuge Y., et al. Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct. Neuropathology 2013, 33(2):140-148.
51. Yasuhara T., Matsukawa N., Hara K., Maki M., Ali M.M., Yu S.J., et al. Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev 2009, 18(10):1501-1514.
52. Bonilla C., Zurita M., Otero L., Aguayo C., Rico M.A., Vaquero J. The severity ofbrain damage determines bone marrow stromal cell therapy efficacy inatraumatic brain injury model. JTrauma Acute Care Surg 2012, 72(5):1203-1212.
53. Zhang Y.J., Zhang W., Lin C.G., Ding Y., Huang S.F., Wu J.L., et al. Neurotrophin-3 gene modified mesenchymal stem cells promote remyelination and functional recovery in the demyelinated spinal cord of rats. JNeurol Sci 2012, 313(1-2):64-74.
54. Karimi-Abdolrezaee S., Eftekharpour E., Wang J., Morshead C.M., Fehlings M.G. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. JNeurosci 2006, 26(13):3377-3389.